Log In
BCIQ
Print this Print this
 

ondansetron (SUD-002)

  Manage Alerts
Collapse Summary General Information
Company Suda Ltd.
DescriptionOral spray formulation of ondansetron
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentDiscovery
Standard IndicationEmesis
Indication DetailsTreat nausea
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today